Simplex Trading’s HealthEquity HQY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $50.1K | Sell |
600
-1,600
| -73% | -$131K | ﹤0.01% | 5881 |
|
|
2025
Q4 | $202K | Buy |
2,200
+2,100
| +2,100% | +$201K | ﹤0.01% | 4228 |
|
|
2025
Q3 | $9K | Sell |
100
-1,900
| -95% | -$179K | ﹤0.01% | 7958 |
|
|
2025
Q2 | $209K | Sell |
2,000
-5,900
| -75% | -$559K | ﹤0.01% | 4446 |
|
|
2025
Q1 | $698K | Buy |
7,900
+7,800
| +7,800% | +$800K | ﹤0.01% | 3038 |
|
|
2024
Q4 | $9K | Sell |
100
-2,600
| -96% | -$242K | ﹤0.01% | 7259 |
|
|
2024
Q3 | $220K | Sell |
2,700
-200
| -7% | -$15.4K | ﹤0.01% | 4428 |
|
|
2024
Q2 | $249K | Sell |
2,900
-1,100
| -28% | -$88.9K | ﹤0.01% | 4433 |
|
|
2024
Q1 | $326K | Buy |
4,000
+3,600
| +900% | +$281K | ﹤0.01% | 4296 |
|
|
2023
Q4 | $26K | Sell |
400
-9,700
| -96% | -$673K | ﹤0.01% | 6700 |
|
|
2023
Q3 | $737K | Buy |
10,100
+5,400
| +115% | +$365K | ﹤0.01% | 2993 |
|
|
2023
Q2 | $296K | Sell |
4,700
-4,200
| -47% | -$244K | ﹤0.01% | 3864 |
|
|
2023
Q1 | $522K | Sell |
8,900
-9,500
| -52% | -$577K | ﹤0.01% | 3222 |
|
|
2022
Q4 | $1.13M | Buy |
18,400
+15,900
| +636% | +$1.07M | ﹤0.01% | 2343 |
|
|
2022
Q3 | $167K | Buy |
2,500
+1,600
| +178% | +$101K | ﹤0.01% | 4856 |
|
|
2022
Q2 | $55K | Sell |
900
-113,300
| -99% | -$7.26M | ﹤0.01% | 6364 |
|
|
2022
Q1 | $7.7M | Buy |
114,200
+100,400
| +728% | +$5.42M | 0.01% | 979 |
|
|
2021
Q4 | $610K | Buy |
13,800
+10,100
| +273% | +$588K | ﹤0.01% | 3534 |
|
|
2021
Q3 | $300K | Hold |
3,700
| – | – | ﹤0.01% | 4910 |
|
|
2021
Q2 | $297K | Buy |
3,700
+3,606
| +3,836% | +$275K | ﹤0.01% | 5006 |
|
|
2021
Q1 | $639K | Sell |
94
-5
| -5% | -$393 | ﹤0.01% | 3003 |
|
|
2020
Q4 | $690K | Sell |
99
-170
| -63% | -$10.6K | ﹤0.01% | 3030 |
|
|
2020
Q3 | $1.38M | Sell |
269
-354
| -57% | -$19.4K | ﹤0.01% | 1893 |
|
|
2020
Q2 | $3.65M | Buy |
623
+367
| +143% | +$20.3K | 0.01% | 1059 |
|
|
2020
Q1 | $1.29M | Buy |
256
+153
| +149% | +$10.2K | ﹤0.01% | 1650 |
|
|
2019
Q4 | $762K | Sell |
103
-271
| -72% | -$16.9K | ﹤0.01% | 2336 |
|
|
2019
Q3 | $2.14M | Buy |
374
+147
| +65% | +$9.76K | 0.01% | 1289 |
|
|
2019
Q2 | $1.48M | Buy |
227
+50
| +28% | +$3.48K | ﹤0.01% | 1551 |
|
|
2019
Q1 | $1.31M | Sell |
177
-133
| -43% | -$9.35K | ﹤0.01% | 1758 |
|
|
2018
Q4 | $1.85M | Buy |
310
+133
| +75% | +$10.7K | 0.01% | 1142 |
|
|
2018
Q3 | $1.67M | Buy |
177
+105
| +146% | +$9.04K | 0.01% | 1399 |
|
|
2018
Q2 | $540K | Sell |
72
-32
| -31% | -$2.3K | ﹤0.01% | 2391 |
|
|
2018
Q1 | $52K | Sell |
104
-9
| -8% | -$487 | ﹤0.01% | 2401 |
|
|
2017
Q4 | $5K | Buy |
+113
| New | +$5.59K | ﹤0.01% | 4498 |
|
|
2017
Q3 | – | Sell |
-108
| Closed | -$5K | – | 6186 |
|
|
2017
Q2 | $5K | Buy |
108
+70
| +184% | +$3.27K | ﹤0.01% | 4577 |
|
|
2017
Q1 | $13K | Buy |
38
+14
| +58% | +$620 | ﹤0.01% | 3712 |
|
|
2016
Q4 | $2K | Buy |
+24
| New | +$928 | ﹤0.01% | 5037 |
|
|
2016
Q1 | – | Sell |
-21
| Closed | -$1K | – | 5862 |
|
|
2015
Q4 | $1K | Buy |
+21
| New | +$645 | ﹤0.01% | 4878 |
|
|
2015
Q3 | – | Sell |
-6
| Closed | -$1K | – | 5783 |
|
|
2015
Q2 | $1K | Buy |
+6
| New | +$161 | ﹤0.01% | 4668 |
|
Other funds holding HQY
WA
VPM
VCM
Simplex Trading's HQY Position: Q4 2025 in Review
Simplex Trading sold out of HealthEquity (HQY) in Q4 2025, closing a stake of 25 shares — an estimated $2.39K sold.
Simplex Trading first reported a position in HQY in Q1 2015 and held it in 23 quarters. The position peaked at $6.33M in Q1 2022. 511 funds tracked by Wall St. Rank hold HQY as of Q4 2025.
- Simplex Trading reported no remaining HealthEquity position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 25 HealthEquity shares in Q4 2025, an estimated $2.39K.
- Simplex Trading first reported a position in HealthEquity in Q1 2015 and held it in 23 quarters.
- Simplex Trading's HealthEquity position peaked at $6.33M in Q1 2022.
- 511 funds tracked by Wall St. Rank held HealthEquity as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.